Two-year outcomes after deployment of XIENCE V everolimus-eluting stents in patients undergoing percutaneous coronary intervention of bifurcation lesions: a report from the SPIRIT V single arm study. [electronic resource]
Producer: 20140418Description: E163-72 p. digitalISSN:- 1522-726X
- Asia
- Canada
- Cardiovascular Agents -- administration & dosage
- Coronary Angiography
- Coronary Artery Disease -- diagnosis
- Coronary Thrombosis -- etiology
- Drug-Eluting Stents
- Europe
- Everolimus
- Female
- Humans
- Male
- Middle Aged
- Myocardial Infarction -- etiology
- New Zealand
- Percutaneous Coronary Intervention -- adverse effects
- Platelet Aggregation Inhibitors -- therapeutic use
- Prospective Studies
- Prosthesis Design
- Risk Factors
- Sirolimus -- administration & dosage
- South Africa
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.